These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Immunohistochemical localization of parathyroid hormone-related protein in canine mammary tumors. Okada H, Nishijima Y, Yoshino T, Grone A, Capen CC, Rosol TJ. Vet Pathol; 1997 Jul; 34(4):356-9. PubMed ID: 9240847 [Abstract] [Full Text] [Related]
12. E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors. Brunetti B, Sarli G, Preziosi R, Monari I, Benazzi C. Vet Pathol; 2005 Nov; 42(6):781-7. PubMed ID: 16301574 [Abstract] [Full Text] [Related]
14. Expression of E-cadherin in normal, hyperplastic and neoplastic feline mammary tissue. Dias Pereira P, Gärtner F. Vet Rec; 2003 Sep 06; 153(10):297-302. PubMed ID: 14509576 [Abstract] [Full Text] [Related]
18. E cadherin expression in normal and neoplastic canine mammary gland. Restucci B, Papparella S, De Vico G, Maiolino P. J Comp Pathol; 1997 Feb 06; 116(2):191-202. PubMed ID: 9131434 [Abstract] [Full Text] [Related]
19. Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas. Figueira AC, Gomes C, de Oliveira JT, Vilhena H, Carvalheira J, de Matos AJ, Pereira PD, Gärtner F. BMC Vet Res; 2014 Nov 26; 10():270. PubMed ID: 25424750 [Abstract] [Full Text] [Related]
20. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues. Faustino AM, van Garderen E, Schalken JA, Nederbragt H. J Comp Pathol; 2002 Jan 26; 126(1):1-8. PubMed ID: 11814316 [Abstract] [Full Text] [Related] Page: [Next] [New Search]